# Open Label, 4 Week Study of ITCA 650 in Adults With Type 2 Diabetes

> **NCT01798264** · PHASE1 · COMPLETED · sponsor: **Intarcia Therapeutics** · enrollment: 44 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** ITCA 650 (exenatide in DUROS)

## Key facts

- **NCT ID:** NCT01798264
- **Lead sponsor:** Intarcia Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2009-05
- **Final completion:** 2009-05
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2013-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01798264

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01798264, "Open Label, 4 Week Study of ITCA 650 in Adults With Type 2 Diabetes". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01798264. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*